| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
2 companies
Owen Adams Catherine is a Chief Executive Officer at ACADIA Pharmaceuticals Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $501K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | ACAD Acadia Pharmaceuticals Inc. | Chief Executive Officer | Sale+OE | 11,641 | $21.47 | $249,932.27 | -44.0% | - | - |